Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

Circulation

Volumn 97, Issue 19, 1998, Pages 1921-1929

  Richards, A Mark ^a   Nicholls, M Gary ^b   Yandle, Tim G ^b   Frampton, Chris ^b   Espiner, Eric A ^b   Turner, John G ^b   Buttimore, Rona C ^b   Lainchbury, John G ^b   Elliott, John M ^b   Ikram, Hamid ^b   Crozier, Ian G ^b   Smyth, David W ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

Atrial natriuretic factor; Brain natriuretic peptide; Myocardial infarction; Peptides; Prognosis; Ventricles

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CYCLIC GMP; HORMONE PRECURSOR; PEPTIDE HORMONE;

ACCURACY; ADULT; AGED; ARTICLE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032546646     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.19.1921     Document Type: Article

References (34)

1. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
2. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
3. Davis KM, Fish LC, Elahi D, Clark BA, Minaker KL. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. JAMA. 1992;267:2625-2629.
4. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol. 1993;72:255-259.
5. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993;341:1105-1109.
6. Hall C, Rouleau JL, Moyè L, de Champlain J, Bichet D, Klein M, Sussex B, Packer M, Rouleau J, Arnold MO. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934-1942.
7. Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol. 1995;76:679-683.
8. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol. 1996;77:828-831.
9. Yamamoto K, Burnett JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-994.
10. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation. 1996;94:690-697.
11. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA, Dickstein K. Plasma brain natriuretic peptide as in indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 1996;93:1963-1969.
12. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996;27:1656-1661.
13. Darber D, Davidson NC, Gillespie N, Choy AMJ, Lang CC, Shyr Y, McNeill GP. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol. 1996;78:284-287.
14. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993;341:1109-1113.
15. Hunt PJ, Yandle TO, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 1995;214: 1175-1183.
16. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT- PROBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997; 47:287-296.
17. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192: 553-560.
18. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett, 1994;338:6-10.
19. Charles CJ, Rademaker MT, Richards AM, Cooper GJS, Coy DH, Jing N, Nicholls MG. Hemodynamic, hormonal and renal effects of adrenomedullin in conscious sheep. Am J Physiol. 1997;41: R2040-R2047.
20. Parkes DG. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol. 1995;268:H2574-H2578.
21. Majid DSA, Kadowitz PJ, Coy DH, Navar LG. Renal responses to intra-arterial administration of adrenomedullin in dogs. Am J Physiol. 1996;270:F200-F205.
22. Richards AM, Nicholls MG, Lewis L, Lainchbury JG. Adrenomedullin. Clin Sci. 1996;91:3-16.
23. Jougasaki M, Rodeheffer RJ, Redfield MM, Yamamoto K, Wei C-M, McKinley LJ, Burnett JC. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest. 1996;97:2370-2376.
24. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab. 1996;81:180-183.
25. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993;76:832-838.
26. Yandle T, Espiner E, Nicholls M, Duff H. Radioimmunoassay and characterisation of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab. 1986;61:71-78.
27. Steiner A, Parker C, Kipnis D. Radioimmunoassay for cyclic nucleotides. J Biol Chem. 1972;247:1106-1113.
28. Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. The measurement of adrenomedullin (1-52) in human plasma by radioimmunoassay: plasma levels, adsorption and storage. Clin Chem. In press.
29. Goldstein DS, Feurstein G, Izzo JL, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 1981;28:467-475.
30. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
31. Sussex BA, Arnold JMO, Parker JO, McEwan P, Rouleau JL, St John-Sutton M, Bernstein V, Rouleau JR, Cuddy TE, Klein M, Nadeau C, Delage F, Sestier F, McCans J. Lamas GA, Gottlieb SS, Geltman E, Plappert T, Moyé L, Braunwald E, Pfeffer MA. Independent and interactive prognostic information of neurohormones and echocardiogram in high risk post-MI patients. J Am Coll Cardiol. 1992;19:205A. Abstract.
32. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 1994;89:1573-1579.
33. Pacher R, Stanek B, Hülsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B. Heinz G, Maurer G. Prognostic impact of big endolhelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol. 1996;27: 633-641.
34. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.